Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench (Q37821488)

23 August 2017

1 reference

title

Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench (English)

1 reference

23 August 2017

Aspergillus fumigatus

0 references

4

Mihai G Netea

1 reference

23 August 2017

Louis Y A Chai

1

1 reference

PubMed ID

21162637

23 August 2017

Alieke G Vonk

series ordinal

2

1 reference

PubMed ID

21162637

23 August 2017

Bart-Jan Kullberg

series ordinal

3

1 reference

23 August 2017

1 January 2011

1 reference

23 August 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

23 August 2017

6

1 reference

23 August 2017

1

1 reference

23 August 2017

73-83

1 reference

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

23 August 2017

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Risk factors for invasive fungal infections in haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Infection in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Towards a targeted, risk-based, antifungal strategy in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Reduced nicotinamide adenine dinucleotide phosphate oxidase-independent resistance to Aspergillus fumigatus in alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Restoration of NET formation by gene therapy in CGD controls aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Susceptibility of mice to invasive aspergillosis correlates with delayed cell influx into the lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Immunity to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

An integrated model of the recognition of Candida albicans by the innate immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Innate immunity to Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Surface hydrophobin prevents immune recognition of airborne fungal spores

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Glucocorticoids and the Th1/Th2 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Mechanisms and resistance in glucocorticoid control of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Human platelets attenuate Aspergillus species via granule-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Transient overexpression of gamma interferon promotes Aspergillus clearance in invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Interleukin-17 family members and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Precarious balance: Th17 cells in host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Th17 cells in the setting of Aspergillus infection and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Antifungal type 1 responses are upregulated in IL-10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Aberrant tissue localization of fungus-specific CD4+ T cells in IL-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Acute graft-versus-host disease: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Impact of mycophenolic acid on the functionality of human polymorphonuclear neutrophils and dendritic cells during interaction with Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.10.158

21 January 2018

Identifiers

DOI

10.2217/FMB.10.158

1 reference

23 August 2017

1 reference

PubMed ID

21162637